<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Consortium PSYCHIATRICUM</journal-id><journal-title-group><journal-title xml:lang="en">Consortium PSYCHIATRICUM</journal-title><trans-title-group xml:lang="ru"><trans-title>Consortium PSYCHIATRICUM</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2712-7672</issn><issn publication-format="electronic">2713-2919</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">171</article-id><article-id pub-id-type="doi">10.17816/CP171</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>RESEARCH</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ИССЛЕДОВАНИЕ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Telomere Length as a Marker of Suicidal Risk in Schizophrenia</article-title><trans-title-group xml:lang="ru"><trans-title>Длина теломер как маркер суицидального риска при шизофрении</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7507-327X</contrib-id><name-alternatives><name xml:lang="en"><surname>Zakharova</surname><given-names>Natalia V.</given-names></name><name xml:lang="ru"><surname>Захарова</surname><given-names>Наталья Вячеславовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, MD, Head of the Laboratory for Fundamental Research Methods of the Scientific Research Center of Neuropsychiatry</p></bio><bio xml:lang="ru"><p>руководитель Лаборатории фундаментальных методов исследования НКИЦ нейропсихиатрии, кандидат медицинских наук</p></bio><email>nataliza80@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5380-4406</contrib-id><name-alternatives><name xml:lang="en"><surname>Bravve</surname><given-names>Lidia V.</given-names></name><name xml:lang="ru"><surname>Бравве</surname><given-names>Лидия Викторовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, psychiatrist, junior researcher of the Laboratory for Fundamental Research Methods of the Scientific Research Center of Neuropsychiatry</p></bio><email>bravve95@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4481-7840</contrib-id><name-alternatives><name xml:lang="en"><surname>Mamedova</surname><given-names>Galina Sh.</given-names></name><name xml:lang="ru"><surname>Мамедова</surname><given-names>Галина Шакировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Clinical resident, assistant of the Laboratory for Fundamental Research Methods of the Scientific Research Center of Neuropsychiatry</p></bio><email>gsh.mamedova@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1516-082X</contrib-id><name-alternatives><name xml:lang="en"><surname>Kaydan</surname><given-names>Maria A.</given-names></name><name xml:lang="ru"><surname>Кайдан</surname><given-names>Мария Андреевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, psychiatrist, junior researcher of the Laboratory for Fundamental Research Methods of the Scientific Research Center of Neuropsychiatry</p></bio><email>kaydan.maria@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1206-5832</contrib-id><name-alternatives><name xml:lang="en"><surname>Ershova</surname><given-names>Elisaveta S.</given-names></name><name xml:lang="ru"><surname>Ершова</surname><given-names>Елизавета Сергеевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD in Biology, leader scientific researcher of the Laboratory of Molecular Biology, Department of Molecular Biology</p></bio><email>es-ershova@rambler.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Martynov</surname><given-names>Andrey V.</given-names></name><name xml:lang="ru"><surname>Мартынов</surname><given-names>Андрей Владимирович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD in Biology, senior scientific researcher of the Laboratory of Molecular Biology, Department of Molecular Biology</p></bio><email>avlamar@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Veiko</surname><given-names>Natalia N.</given-names></name><name xml:lang="ru"><surname>Вейко</surname><given-names>Наталья Николаевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD in Biology, chief scientific researcher of the Laboratory of Molecular Biology, Department of Molecular Biology</p></bio><email>satelit32006@yandex.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kostyuk</surname><given-names>Svetlana V.</given-names></name><name xml:lang="ru"><surname>Костюк</surname><given-names>Светлана Викторовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD in Biology, Head of the Laboratory of Molecular Biology, Department of Molecular Biology</p></bio><email>svet-vk@yandex.ru</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Mental Health Сlinic No.1 named after N.A. Alexeev</institution></aff><aff><institution xml:lang="ru">ГБУЗ «Психиатрическая клиническая больница № 1 им. Н.А. Алексеева Департамента здравоохранения города Москвы»</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Research Center for Medical Genetics</institution></aff><aff><institution xml:lang="ru">ФГБНУ «Медико-генетический научный центр им. Н.П. Бочкова»</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2022-06-21" publication-format="electronic"><day>21</day><month>06</month><year>2022</year></pub-date><pub-date date-type="pub" iso-8601-date="2022-07-05" publication-format="electronic"><day>05</day><month>07</month><year>2022</year></pub-date><volume>3</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>37</fpage><lpage>47</lpage><history><date date-type="received" iso-8601-date="2022-03-29"><day>29</day><month>03</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-05-30"><day>30</day><month>05</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2022, Zakharova N.V., Bravve L.V., Mamedova G.S., Kaydan M.A., Ershova E.S., Martynov A.V., Veiko N.N., Kostyuk S.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2022, Захарова Н.В., Бравве Л.В., Мамедова Г.Ш., Кайдан М.А., Ершова Е.С., Мартынов А.В., Вейко Н.Н., Костюк С.В.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="en">Zakharova N.V., Bravve L.V., Mamedova G.S., Kaydan M.A., Ershova E.S., Martynov A.V., Veiko N.N., Kostyuk S.V.</copyright-holder><copyright-holder xml:lang="ru">Захарова Н.В., Бравве Л.В., Мамедова Г.Ш., Кайдан М.А., Ершова Е.С., Мартынов А.В., Вейко Н.Н., Костюк С.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://consortium-psy.com/jour/article/view/171">https://consortium-psy.com/jour/article/view/171</self-uri><abstract xml:lang="en"><p><bold>BACKGROUND</bold>: Schizophrenia and suicidal behavior are associated with shortening in the length of telomeres. The aim of the study was to compare the content (pg/mcg) of telomeric repeat in DNA isolated from peripheral blood cells in three groups of subjects: patients with schizophrenia and a history of suicide attempts, patients with schizophrenia without suicidal tendencies, and healthy control volunteers.</p> <p><bold>METHODS</bold>: Relapses according to gender and age were examined in 47 patients with schizophrenia with suicidal behavior, 47 patients without self-destructive conditions, and 47 volunteers with healthy control and maintenance for the content of telomeric and the number of copies of mitochondrial DNA (mtDNA) in peripheral blood leukocytes.</p> <p><bold>RESULTS</bold>: Analysis of determining the content of telomeric repeat (TR) in the DNA of massive weight gain in the series: patients with schizophrenia and suicidal attempts — patients with schizophrenia without suicidal observations — healthy controls (225±28.4 (227 [190; 250]) vs. 243±21 (245 [228; 260]) vs. 255±17.9 (255 [242; 266]), p &lt;0.005. The same trend is observed for the number of mtDNA copies (257±101.5 (250 [194; 297])) vs. 262.3±59.3 (254 [217; 312]) vs. 272±79.9 (274 [213; 304]); p=0.012), but no significant differences were recorded.</p> <p><bold>CONCLUSIONS</bold>: For the first time, the phenomenon of telomere shortening was discovered in schizophrenics with suicidal risk. The length of the telomere corresponds to the parameter of a biological marker — an objectively measured indicator of normal or pathological processes, but gaining an idea of its reliability is still necessary for verification with an assessment of its sensitivity, specificity, and positive and negative predictive value. The telomere may be considered a putative predictive indicator of suicidal risk.</p></abstract><trans-abstract xml:lang="ru"><p><bold>ВВЕДЕНИЕ</bold>: Шизофрения и суицидальное поведение сопряжены с укорочением длины теломер. Целью исследования стало сравнение содержания (пг/мкг) теломерного повтора в ДНК, выделенной из клеток периферической крови, у трех групп испытуемых: пациентов с шизофренией и суицидами в анамнезе, пациентов с шизофренией без суицидов и добровольцев из числа здорового контроля.</p> <p><bold>МЕТОДЫ</bold>: Обследованы сопоставимые по полу и возрасту 47 пациентов с шизофренией с суицидальным поведением, 47 больных без аутодеструктивных тенденций и 47 добровольцев здорового контроля клинически и на предмет содержания теломерного повтора в ДНК лейкоцитов крови.</p> <p><bold>РЕЗУЛЬТАТЫ</bold>: Анализ определения содержания теломерного повтора (TR) в ДНК свидетельствует о статистически значимом увеличении длины теломер в ряду: пациенты с шизофренией и суицидами — пациенты с шизофренией без суицидов — здоровый контроль (225 vs 224 vs 255; p=0,024). Такой же тренд прослеживается для концентрации митохондриальной ДНК (мтДНК) (257 vs 262 vs 272; p=0,012).</p> <p><bold>ВЫВОДЫ</bold>: Впервые установили феномен укорочения длины теломер при шизофрении, сопряженной с суицидальным риском. Длина теломер отвечает параметрам биологического маркера — объективно измеряемого показателя нормальных или патологических процессов, но его валидность еще необходимо проверить с оценкой его чувствительности, специфичности, положительной и отрицательной прогностической ценности. Рассматривать длину теломер как прогностический индикатор суицидального риска преждевременно.</p></trans-abstract><kwd-group xml:lang="en"><kwd>schizophrenia</kwd><kwd>suicide</kwd><kwd>telomere length</kwd><kwd>mtDNA</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>шизофрения</kwd><kwd>суицид</kwd><kwd>длина теломер</kwd><kwd>мтДНК</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution xml:lang="en">Russian Science Foundation</institution></institution-wrap><institution-wrap><institution xml:lang="ru">Российский научный фонд</institution></institution-wrap></funding-source><award-id>18-15-00437</award-id></award-group></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Nordentoft M, Jeppesen P, Abel M, Kassow P, Petersen L, Thorup A, Krarup G, Hemmingsen R, Jorgensen P. OPUS study: suicidal behaviour, suicidal ideation and hopelessness among patients with first-episode psychosis. One-year follow-up of a randomised controlled trial. Br J Psychiatry Suppl. 2002 Sep;43:s98–106. doi: 10.1192/bjp.181.43.s98.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry. 2007 Oct;64(10):1123–1131. doi: 10.1001/archpsyc.64.10.1123.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Moussaoui D, El Hamaoui Y. Faculty Opinions recommendation of A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? // Faculty Opinions — Post-Publication Peer Review of the Biomedical Literature. 2008.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Luhr R, Cao Y, Soderquist B, Cajander S. Trends in sepsis mortality over time in randomised sepsis trials: a systematic literature review and meta-analysis of mortality in the control arm, 2002–2016. Crit Care. 2019 Jul 3;23(1):241. doi: 10.1186/s13054-019-2528-0.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Hor K, Taylor M. Suicide and schizophrenia: a systematic review of rates and risk factors. J Psychopharmacol. 2010 Nov; 24(4 Suppl):81–90. doi: 10.1177/1359786810385490.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Roy A, Pompili M. Management of schizophrenia with suicide risk. Psychiatr Clin North Am. 2009 Dec;32(4):863–883. doi: 10.1016/j.psc.2009.08.005.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Pompili M, Fiorillo A. Preventing Suicide in Patients with Mental Disorders. Basel: MDPI; 2020. 148 p.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Sadek J. A Clinician’s Guide to Suicide Risk Assessment and Management. Springer; 2018. 113 p.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Agerbo E. High income, employment, postgraduate education, and marriage: a suicidal cocktail among psychiatric patients. Arch Gen Psychiatry. 2007 Dec;64(12):1377–1384. doi: 10.1001/archpsyc.64.12.1377.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Healy D, Le Noury J, Harris M, Butt M, Linden S, Whitaker C, Zou L, Roberts AP. Mortality in schizophrenia and related psychoses: data from two cohorts, 1875–1924 and 1994–2010. BMJ Open. 2012;2(5). doi: 10.1136/bmjopen-2012-001810.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Montross LP, Zisook S, Kasckow J. Suicide Among Patients with Schizophrenia: A Consideration of Risk and Protective Factors. Annals of Clinical Psychiatry. 2005;17(3):173–182.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Kasckow J, Felmet K, Zisook S. Managing suicide risk in patients with schizophrenia. CNS Drugs. 2011 Feb;25(2):129–143. doi: 10.2165/11586450-000000000-00000.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Thong JY, Su AH, Chan YH, Chia BH. Suicide in psychiatric patients: case-control study in Singapore. Aust N Z J Psychiatry. 2008 Jun;42(6):509–519. doi: 10.1080/00048670802050553.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Hunt IM, Kapur N, Webb R, Robinson J, Burns J, Shaw J, Appleby L. Suicide in recently discharged psychiatric patients: a case-control study. Psychol Med. 2009 Mar;39(3):443–449. doi: 10.1017/S0033291708003644.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Miles CP. Conditions predisposing to suicide: a review. J Nerv Ment Dis. 1977 Apr;164(4):231–246. doi: 10.1097/00005053-197704000-00002.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Kirkpatrick B, Messias E, Harvey PD, Fernandez-Egea E, Bowie CR. Is schizophrenia a syndrome of accelerated aging? Schizophr Bull. 2008 Nov;34(6):1024–1032. doi: 10.1093/schbul/sbm140.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Shivakumar V, Kalmady SV, Venkatasubramanian G, Ravi V, Gangadhar BN. Do schizophrenia patients age early? Asian J Psychiatr. 2014 Aug;10:3–9. doi: 10.1016/j.ajp.2014.02.007.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Okusaga OO. Accelerated aging in schizophrenia patients: the potential role of oxidative stress. Aging Dis. 2014 Aug; 5(4):256–262. doi: 10.14336/AD.2014.0500256.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Polho GB, De-Paula VJ, Cardillo G, dos Santos B, Kerr DS. Leukocyte telomere length in patients with schizophrenia: A meta-analysis. Schizophr Res. 2015 Jul;165(2-3):195–200. doi: 10.1016/j.schres.2015.04.025.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Papanastasiou E, Gaughran F, Smith S. Schizophrenia as segmental progeria. J R Soc Med. 2011 Nov;104(11):475–484. doi: 10.1258/jrsm.2011.110051.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Savolainen K, Raikkonen K, Kananen L, Kajantie E, Hovatta I, Lahti M, Lahti J, Pesonen AK, Heinonen K, Eriksson JG. History of mental disorders and leukocyte telomere length in late adulthood: the Helsinki Birth Cohort Study (HBCS). J Psychiatr Res. 2012 Oct;46(10):1346–1353. doi: 10.1016/j.jpsychires.2012.07.005.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>de Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res. 2005 Jul 15;76(2-3):135–157. doi: 10.1016/j.schres.2005.02.010.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Mittal D, Corrigan P, Sherman MD, Chekuri L, Han X, Reaves C, Mukherjee S, Morris S, Sullivan G. Healthcare providers’ attitudes toward persons with schizophrenia. Psychiatr Rehabil J. 2014 Dec;37(4):297–303. doi: 10.1037/prj0000095.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Eitan E, Hutchison ER, Mattson MP. Telomere shortening in neurological disorders: an abundance of unanswered questions. Trends Neurosci. 2014 May;37(5):256–263. doi: 10.1016/j.tins.2014.02.010.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Kawanishi S, Oikawa S. Mechanism of telomere shortening by oxidative stress. Ann N Y Acad Sci. 2004 Jun;1019:278–284. doi: 10.1196/annals.1297.047.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Hossein Fatemi S. The Molecular Basis of Autism. Springer, 2015. 437 p.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Kim JH, Kim HK, Ko JH, Bang H, Lee DC. The relationship between leukocyte mitochondrial DNA copy number and telomere length in community-dwelling elderly women. PLoS One. 2013;8(6):e67227. doi: 10.1371/journal.pone.0067227.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Li Z, Hu M, Zong X, He Y, Wang D, Dai L, Dong M, Zhou J, Cao H, Lv L, et al. Association of telomere length and mitochondrial DNA copy number with risperidone treatment response in first-episode antipsychotic-naive schizophrenia. Sci Rep. 2015 Dec 18;5:18553. doi: 10.1038/srep18553.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Picard M, Zhang J, Hancock S, Derbeneva O, Golhar R, Golik P, O’Hearn S, Levy S, Potluri P, Lvova M, et al. Progressive increase in mtDNA 3243A&gt;G heteroplasmy causes abrupt transcriptional reprogramming. Proc Natl Acad Sci U S A. 2014 Sep 23;111(38):E4033–4042. doi: 10.1073/pnas.1414028111.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Lagouge M, Larsson NG. The role of mitochondrial DNA mutations and free radicals in disease and ageing. J Intern Med. 2013 Jun;273(6):529–543. doi: 10.1111/joim.12055.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Spano L, Etain B, Meyrel M, Hennion V, Gross G, Laplanche JL, Bellivier F, Marie-Claire C. Telomere length and mitochondrial DNA copy number in bipolar disorder: identification of a subgroup of young individuals with accelerated cellular aging. Transl Psychiatry. 2022 Apr 1;12(1):135. doi: 10.1038/s41398-022-01891-4.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Wang D, Li Z, Liu W, Zhou J, Ma X, Tang J, Chen X. Differential mitochondrial DNA copy number in three mood states of bipolar disorder. BMC Psychiatry. 2018 May 25;18(1):149. doi: 10.1186/s12888-018-1717-8.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Kageyama Y, Deguchi Y, Kasahara T, Tani M, Kuroda K, Inoue K, Kato T. Intra-individual state-dependent comparison of plasma mitochondrial DNA copy number and IL-6 levels in patients with bipolar disorder. J Affect Disord. 2022 Feb 15;299:644–651. doi: 10.1016/j.jad.2021.10.098.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Bhat AH, Dar KB, Anees S, Zargar MA, Masood A, Sofi MA, Ganie SA. Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight. Biomed Pharmacother. 2015 Aug;74:101–110. doi: 10.1016/j.biopha.2015.07.025.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Fernandez-Egea E, Bernardo M, Heaphy CM, Griffith JK, Parellada E, Esmatjes E, Conget I, Nguyen L, George V, Stoppler H, et al. Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis. Schizophr Bull. 2009 Mar;35(2):437–442. doi: 10.1093/schbul/sbn169.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Kao HT, Cawthon RM, Delisi LE, Bertisch HC, Ji F, Gordon D, Li P, Benedict MM, Greenberg WM, Porton B. Rapid telomere erosion in schizophrenia. Mol Psychiatry. 2008 Feb;13(2):118–119. doi: 10.1038/sj.mp.4002105.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Nieratschker V, Lahtinen J, Meier S, Strohmaier J, Frank J, Heinrich A, Breuer R, Witt SH, Nothen MM, Rietschel M, et al. Longer telomere length in patients with schizophrenia. Schizophr Res. 2013 Sep;149(1–3):116–120. doi: 10.1016/j.schres.2013.06.043.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Mansour H, Chowdari K, Fathi W, Elassy M, Ibrahim I, Wood J, Bamne M, Tobar S, Yassin A, Salah H, et al. Does telomere length mediate associations between inbreeding and increased risk for bipolar I disorder and schizophrenia? Psychiatry Res. 2011 Jun 30;188(1):129–132. doi: 10.1016/j.psychres.2011.01.010.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Zhang D, Cheng L, Craig DW, Redman M, Liu C. Cerebellar telomere length and psychiatric disorders. Behav Genet. 2010 Mar;40(2):250–254. doi: 10.1007/s10519-010-9338-0.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Malaspina D, Dracxler R, Walsh-Messinger J, Harlap S, Goetz RR, Keefe D, Perrin MC. Telomere length, family history, and paternal age in schizophrenia. Mol Genet Genomic Med. 2014 Jul;2(4):326–331. doi: 10.1002/mgg3.71.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Darrow SM, Verhoeven JE, Revesz D, Lindqvist D, Penninx BW, Delucchi KL, Wolkowitz OM, Mathews CA. The Association Between Psychiatric Disorders and Telomere Length: A Meta-Analysis Involving 14,827 Persons. Psychosom Med. 2016 Sep;78(7):776–787. doi: 10.1097/PSY.0000000000000356.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Russo P, Prinzi G, Proietti S, Lamonaca P, Frustaci A, Boccia S, Amore R, Lorenzi M, Onder G, Marzetti E, et al. Shorter telomere length in schizophrenia: Evidence from a real-world population and meta-analysis of most recent literature. Schizophr Res. 2018 Dec;202:37–45. doi: 10.1016/j.schres.2018.07.015.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Tyrka AR, Parade SH, Price LH, Kao HT, Porton B, Philip NS, Welch ES, Carpenter LL. Alterations of Mitochondrial DNA Copy Number and Telomere Length With Early Adversity and Psychopathology. Biol Psychiatry. 2016 Jan 15;79(2):78–86. doi: 10.1016/j.biopsych.2014.12.025.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Kang JI, Park CI, Lin J, Kim ST, Kim HW, Kim SJ. Alterations of cellular aging markers in obsessive- compulsive disorder: mitochondrial DNA copy number and telomere length. J Psychiatry Neurosci. 2021 Jul 22;46(4):E451–E458. doi: 10.1503/jpn.200238.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Tyrka AR, Carpenter LL, Kao HT, Porton B, Philip NS, Ridout SJ, Ridout KK, Price LH. Association of telomere length and mitochondrial DNA copy number in a community sample of healthy adults. Exp Gerontol. 2015 Jun;66:17–20. doi: 10.1016/j.exger.2015.04.002.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Otsuka I, Izumi T, Boku S, Kimura A, Zhang Y, Mouri K, Okazaki S, Shiroiwa K, Takahashi M, Ueno Y, et al. Aberrant telomere length and mitochondrial DNA copy number in suicide completers. Sci Rep. 2017 Jun 9;7(1):3176. doi: 10.1038/s41598-017-03599-8.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Kim H, Cho SJ, Yoo SH, Kim SH, Ahn YM. Association between telomere length and completed suicide observed in 71 suicide victims — Preliminary findings. J Psychosom Res. 2019 May; 120:8–11. doi: 10.1016/j.jpsychores.2019.02.008.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Birkenaes V, Elvsashagen T, Westlye LT, Hoegh MC, Haram M, Werner MCF, Quintana DS, Lunding SH, Martin-Ruiz C, Agartz I, et al. Telomeres are shorter and associated with number of suicide attempts in affective disorders. J Affect Disord. 2021 Dec 1;295:1032–1039. doi: 10.1016/j.jad.2021.08.135.</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–276. doi: 10.1093/schbul/13.2.261.</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Ershova ES, Malinovskaya EM, Konkova MS, Veiko RV, Umriukhin PE, Martynov AV, Kutsev SI, Veiko NN, Kostyuk SV. Copy Number Variation of Human Satellite III (1q12) With Aging. Front Genet. 2019;10:704. doi: 10.3389/fgene.2019.00704.</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Ershova ES, Jestkova EM, Martynov AV, Shmarina GV, Umriukhin PE, Bravve LV, Zakharova NV, Kostyuk GP, Saveliev DV, Orlova MD, et al. Accumulation of Circulating Cell-Free CpG-Enriched Ribosomal DNA Fragments on the Background of High Endonuclease Activity of Blood Plasma in Schizophrenic Patients. Int J Genomics. 2019;2019:8390585. doi: 10.1155/2019/8390585.</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Chestkov IV, Jestkova EM, Ershova ES, Golimbet VE, Lezheiko TV, Kolesina NY, Porokhovnik LN, Lyapunova NA, Izhevskaya VL, Kutsev SI, et al. Abundance of ribosomal RNA gene copies in the genomes of schizophrenia patients. Schizophr Res. 2018 Jul;197:305–314. doi: 10.1016/j.schres.2018.01.001.</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Chestkov IV, Jestkova EM, Ershova ES, Golimbet VG, Lezheiko TV, Kolesina NY, Dolgikh OA, Izhevskaya VL, Kostyuk GP, Kutsev SI, et al. ROS-Induced DNA Damage Associates with Abundance of Mitochondrial DNA in White Blood Cells of the Untreated Schizophrenic Patients. Oxid Med Cell Longev. 2018;2018:8587475. doi: 10.1155/2018/8587475.</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Andreasen NC, Pressler M, Nopoulos P, Miller D, Ho BC. Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol Psychiatry. 2010 Feb 1;67(3):255–262. doi: 10.1016/j.biopsych.2009.08.040.</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Cassidy RM, Yang F, Kapczinski F, Passos IC. Risk Factors for Suicidality in Patients With Schizophrenia: A Systematic Review, Meta-analysis, and Meta-regression of 96 Studies. Schizophr Bull. 2018 Jun 6;44(4):787–797. doi: 10.1093/schbul/sbx131.</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>De Hert M, McKenzie K, Peuskens J. Risk factors for suicide in young people suffering from schizophrenia: a long-term follow-up study. Schizophr Res. 2001 Mar 1;47(2-3):127–134. doi: 10.1016/s0920-9964(00)00003-7.</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Modestin J, Zarro I, Waldvogel D. A study of suicide in schizophrenic in-patients. Br J Psychiatry. 1992 Mar;160:398–401. doi: 10.1192/bjp.160.3.398.</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Pinikahana J, Happell B, Keks NA. Suicide and schizophrenia: a review of literature for the decade (1990–1999) and implications for mental health nursing. Issues Ment Health Nurs. 2003 Jan-Feb;24(1):27–43. doi: 10.1080/01612840305305.</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Siris SG. Suicide and schizophrenia. J Psychopharmacol. 2001 Jun;15(2):127–135. doi: 10.1177/026988110101500209.</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>Pompili M, Amador XF, Girardi P, Harkavy-Friedman J, Harrow M, Kaplan K, Krausz M, Lester D, Meltzer HY, Modestin J, et al. Suicide risk in schizophrenia: learning from the past to change the future. Ann Gen Psychiatry. 2007 Mar 16;6:10. doi: 10.1186/1744-859X-6-10.</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Altamura AC, Bassetti R, Bignotti S, Pioli R, Mundo E. Clinical variables related to suicide attempts in schizophrenic patients: a retrospective study. Schizophr Res. 2003 Mar 1;60(1):47–55. doi: 10.1016/s0920-9964(02)00164-0.</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>Mauri MC, Paletta S, Maffini M, Moliterno D, Altamura AC. Suicide attempts in schizophrenic patients: clinical variables. Asian J Psychiatr. 2013 Oct;6(5):421–427. doi: 10.1016/j.ajp.2013.07.001.</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>Bousman CA, Glatt SJ, Chandler SD, Lohr J, Kremen WS, Tsuang MT, Everall IP. Negative Symptoms of Psychosis Correlate with Gene Expression of the Wnt/beta-Catenin Signaling Pathway in Peripheral Blood. Psychiatry J. 2013;2013:852930. doi: 10.1155/2013/852930.</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation>Porton B, Delisi LE, Bertisch HC, Ji F, Gordon D, Li P, Benedict MM, Greenberg WM, Kao HT. Telomerase levels in schizophrenia: a preliminary study. Schizophr Res. 2008 Dec;106(2-3):242–247. doi: 10.1016/j.schres.2008.08.028.</mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation>Maurya PK, Rizzo LB, Xavier G, Tempaku PF, Ota VK, Santoro ML, Spindola LM, Moretti PS, Mazzotti DR, Gadelha A, et al. Leukocyte telomere length variation in different stages of schizophrenia. J Psychiatr Res. 2018 Jan;96:218–223. doi: 10.1016/j.jpsychires.2017.10.016.</mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation>Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev. 2011 Mar;63(1):182–217. doi: 10.1124/pr.110.002642.</mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation>Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet. 2004 Feb;36(2):131–137. doi: 10.1038/ng1296.</mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation>Li X, Jope RS. Is glycogen synthase kinase-3 a central modulator in mood regulation? Neuropsychopharmacology. 2010 Oct; 35(11):2143–2154. doi: 10.1038/npp.2010.105.</mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation>Yu WY, Chang HW, Lin CH, Cho CL. Short telomeres in patients with chronic schizophrenia who show a poor response to treatment. J Psychiatry Neurosci. 2008 May;33(3):244–247.</mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation>Kota LN, Purushottam M, Moily NS, Jain S. Shortened telomere in unremitted schizophrenia. Psychiatry Clin Neurosci. 2015 May;69(5):292–297. doi: 10.1111/pcn.12260.</mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation>Kumar P, Efstathopoulos P, Millischer V, Olsson E, Wei YB, Brustle O, Schalling M, Villaescusa JC, Osby U, Lavebratt C. Mitochondrial DNA copy number is associated with psychosis severity and anti-psychotic treatment. Sci Rep. 2018 Aug 24;8(1):12743. doi: 10.1038/s41598-018-31122-0.</mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation>Roberts CK, Sindhu KK. Oxidative stress and metabolic syndrome. Life Sci. 2009 May 22;84(21-22):705–712. doi: 10.1016/j.lfs.2009.02.026.</mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation>Emanuela F, Grazia M, Marco de R, Maria Paola L, Giorgio F, Marco B. Inflammation as a Link between Obesity and Metabolic Syndrome. J Nutr Metab. 2012;2012:476380. doi: 10.1155/2012/476380.</mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation>Weischer M, Bojesen SE, Nordestgaard BG. Telomere shortening unrelated to smoking, body weight, physical activity, and alcohol intake: 4,576 general population individuals with repeat measurements 10 years apart. PLoS Genet. 2014 Mar; 10(3):e1004191. doi: 10.1371/journal.pgen.1004191.</mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation>Rizvi S, Raza ST, Mahdi F. Telomere length variations in aging and age-related diseases. Curr Aging Sci. 2014;7(3):161–167. doi: 10.2174/1874609808666150122153151.</mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation>Corfdir C, Pignon B, Szoke A, Schurhoff F. [Accelerated telomere erosion in schizophrenia: A literature review]. Encephale. 2021 Aug;47(4):369–375. doi: 10.1016/j.encep.2020.12.001.</mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation>Kimura M, Cherkas LF, Kato BS, Demissie S, Hjelmborg JB, Brimacombe M, Cupples A, Hunkin JL, Gardner JP, Lu X, et al. Offspring’s leukocyte telomere length, paternal age, and telomere elongation in sperm. PLoS Genet. 2008 Feb;4(2):e37. doi: 10.1371/journal.pgen.0040037.</mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation>Prescott J, Du M, Wong JY, Han J, De Vivo I. Paternal age at birth is associated with offspring leukocyte telomere length in the nurses’ health study. Hum Reprod. 2012 Dec;27(12):3622–3631. doi: 10.1093/humrep/des314.</mixed-citation></ref></ref-list></back></article>
